A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis
Systemic atopic dermatitis treatments that have acceptable safety are needed.To evaluate the safety of the oral Janus kinase inhibitor upadacitinib in combination with topical corticosteroids (TCSs) for the treatment of atopic dermatitis.In this phase 3, double-blind study (Rising Up), Japanese pati...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2021
|
| 在線閱讀: | https://doi.org/10.1016/j.jdin.2021.11.001 http://www.jaadinternational.org/article/S2666328721000894/pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|